Navigation Links
Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
Date:3/16/2009

X-ray tubes, including one capable of completing a full CT (computed tomography) scan in half a second."

"Varian is pleased to be showcasing its radiotherapy and X-ray products at China Med this year and to be expanding its operations in China," said Ling Zhang, Varian's marketing manager in Beijing, where the company manufactures radiotherapy machines and provides clinical training for medical professionals who treat cancer. Varian's facility in Beijing is also gearing up to manufacture X-ray tubes.

The China Med exhibition will be take place at the China International Exhibition Center in Beijing from March 19-21, 2009.

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in China, North America and Europe and in its 60 sales and support offices around the world. For more information, visit our website:

English: http://www.varian.com/

Simplified Chinese: http://www.varian.com/ascns/index.html

Traditional Chinese: http://www.varian.com/ascnt/index.html

    Ling Zhang, M.D.              
'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
2. Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
3. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
4. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
5. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
6. Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
7. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
8. Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
9. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
10. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
11. Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Alberta , Sept. 16, 2014  Wearable ... billion industry in less than two years, producing ... the way. A huge opportunity exists for leveraging ... Vivametrica ( http://vivametrica.com/our-video/ ) introduced a first-of-its-kind wearable ... based on years of clinical research linking activity ...
(Date:9/16/2014)...  Eli Lilly and Company (NYSE: ... to co-develop and commercialize AZD3293, an oral beta ... as a potential treatment for Alzheimer,s disease. ... by the accumulation of amyloid plaque in the ... development of beta-amyloid. Inhibiting BACE is expected to ...
(Date:9/15/2014)... PARIS and NEW YORK ... company Pharnext SAS and the Hereditary Neuropathy Foundation (HNF) ... increase the awareness around Charcot-Marie-Tooth (CMT) disease and support ... community. Pharnext will provide financial support ... design and development of a specific section in the ...
Breaking Medicine Technology:Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 2Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 2Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 4Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4
... Accelerated Community Oncology,Research Network(TM) (ACORN) will ... Guardian EDC(TM); PACE(TM) PRO System; and,proprietary oncology-focused ... Meeting,June 22-26, in Boston, MA., (Logo: ... 2008 the company announced its Contract Research ...
... iCAD, Inc. (Nasdaq:,ICAD), an industry-leading provider of ... cancer, today announced it has,initiated a clinical study ... partnership with ACR Image Metrix, a subsidiary of ... Image Metrix, having completed the,development portion of the ...
Cached Medicine Technology:ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting 2iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 2iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 3iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 4
(Date:9/16/2014)... 16, 2014 LiveOps, the global ... solutions, announced today that the company has received ... for the creation of a social learning ecosystem ... Hall Group honors companies that have successfully developed ... tools that have helped companies achieve measurable results. ...
(Date:9/16/2014)... 16, 2014 Former Major League Baseball ... undergoing successful heart transplantation surgery at Allegheny General Hospital ... spent most of his 16-year baseball career with the ... commentator for Root Sports Pittsburgh, was discharged home on ... Bailey, MD, surgical director of AGH’s heart transplant program. ...
(Date:9/16/2014)... September 15, 2014Patients with inoperable, early-stage lung cancer ... a five-year survival rate of 40 percent, according ... for Radiation Oncology,s (ASTRO,s) 56th Annual Meeting. Such ... historically conventional RT resulted in poor tumor control ... is an update of RTOG 0236, originally published ...
(Date:9/16/2014)... who tend to be on the heavy side. Researchers ... found that seven in every ten obese adults underestimate ... this mistake much less often. Mothers of overweight or ... as youngsters misjudge their obese mothers, size, says lead ... a study in the Journal of General Internal ...
(Date:9/16/2014)... Poster Discussion abstracts to be presented at the ESMO ... September 2014 at 12:00 (CEST) to give you a ... European medical oncology Congress, under the leading theme Precision ... point where genuinely targeted therapy is now possible for ... we are all working towards a common goal --improved ...
Breaking Medicine News(10 mins):Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 3Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 4Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 3Health News:Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates 2Health News:Long-term results of RTOG 0236 confirm good primary tumor control, positive 5-year survival rates 3Health News:Poor body size judgement can lead to increased tolerance of obesity 2Health News:ESMO 2014 Congress Preview 2
... Chief Financial Officer, OAKLAND, Calif., July 1 ... ("WorldHeart" or the "Corporation") announced today,that, on June ... NASDAQ Stock,Market stating that the Corporation does not ... requires the Corporation to maintain,a minimum market value ...
... Somanetics Corporation,(Nasdaq: SMTS ) announced today that ... up to an additional $15 million of its common,shares ... shares). Purchases may be,made from time to time in ... timing and amount of, and purposes for, any,purchases will ...
... development, researcher says , , TUESDAY, July 1 (HealthDay News) ... numerous painful interventions, not enough is being done to ... 42,413 painful procedures included in this study, only 2 ... percent received non-pharmacological pain therapy. That means about four ...
... PHILADELPHIA - Researchers at the University of Pennsylvania School ... vaccinate against avian flu. By delivering vaccine via DNA ... minute electric pulse, researchers have immunized experimental animals against ... for the build up of vaccine reserves that could ...
... July 1, 2008 Researchers have found that a ... varieties of adult rheumatoid arthritis is also present in ... responsible gene may be a "master switch" that helps ... Children,s Hospital of Philadelphia reported on the link between ...
... close to patient pinpointed who was likely to progress to ... questionnaire may help in both diagnosing older adults facing dementia ... living. , The Everyday Cognition instrument consists of 39 questions ... , "There have been a number of studies that show ...
Cached Medicine News:Health News:WorldHeart Receives Non-Compliance Letter From NASDAQ Stock Market 2Health News:WorldHeart Receives Non-Compliance Letter From NASDAQ Stock Market 3Health News:Somanetics Announces Share Repurchase Program Increased By $15 Million 2Health News:Newborns in Intensive Care Often Exposed to Pain 2Health News:Newborns in Intensive Care Often Exposed to Pain 3Health News:Penn animal study identifies new DNA weapon against avian flu 2Health News:Penn animal study identifies new DNA weapon against avian flu 3Health News:Pediatric researchers find possible 'master switch' gene in juvenile arthritis 2Health News:Mental Test Spots Alzheimer's Risk 2Health News:Mental Test Spots Alzheimer's Risk 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: